Potential biomarkers of immune protection in human leishmaniasis Mahmoud Nateghi RostamiAli Khamesipour Review 02 May 2021 Pages: 81 - 100
An update: the emerging evidence of complement involvement in COVID-19 Qin LiZi Chen Review Open access 03 April 2021 Pages: 101 - 109
Comparison of specific in-vitro virulence gene expression and innate host response in locally invasive vs colonizer strains of Streptococcus pneumoniae Naoko FujiMichael E. PichicheroRavinder Kaur Original Investigation 22 March 2021 Pages: 111 - 120
Long non-coding RNA NEAT1 promotes lipopolysaccharide-induced injury in human tubule epithelial cells by regulating miR-93-5p/TXNIP axis Jing YangLin WuLiying Fang Original Investigation 22 April 2021 Pages: 121 - 132
Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis Rafaella R. CostaJoão A. Oliveira-da-SilvaEduardo A. F. Coelho Original Investigation 18 April 2021 Pages: 133 - 147
The role of HIF-1α in BCG-stimulated macrophages polarization and their tumoricidal effects in vitro Pei ZhuYuyang HouZehua Dong Original Investigation 11 May 2021 Pages: 149 - 156
What we actually know about the pathogenicity of Bacteroides pyogenes Anna MajewskaMarta KierzkowskaDariusz Kawecki Original Investigation Open access 02 May 2021 Pages: 157 - 163
Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission Friederike HäuserMartin F. SprinzlNiels A. Lemmermann Rapid Communication Open access 15 April 2021 Pages: 165 - 171